West Virginia heart surgeon reinvents approach to aortic valve repairs with new device
To better treat patients with aortic valve disease, J. Scott Rankin, MD, a surgeon at the West Virginia University Heart and Vascular Institute in Morgantown has developed the HAART 300 Aortic Annuloplasty Device—and it just received approval U.S. Food and Drug Administration this week.
The device, manufactured by BioStable Science & Engineering, is the first internal annuloplasty device design to repair aortic valves that has become commercially available.
“Dr. Rankin has truly helped usher in an entirely new way of repairing aortic valves,” said Vinay Badhwar, MD, executive chair of the WVU Heart and Vascular Institute. “He has created a new class of heart operation that could potentially save thousands of patients who currently are otherwise treated with artificial heart valves. Dr. Rankin’s global contributions are a shining example of the mission of WVU Heart and Vascular Institute and West Virginia University.”
To read the full story, follow the link below:
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.